DEMONSTRATE LARGE ANIMAL EFFICACY, DEFINE PROTOCOLS FOR THE PIVOTAL ANIMAL TRIAL, AND BETTER UNDERSTAND THE PHARMACODYNAMICS OF TP508. TO ACHIEVE THIS OBJECTIVE, WE WILL CONDUCT NON-CLINICAL EFFICACY SURVIVAL STUDIES IN MALE AND FEMALE MINIPIGS WITH
$24,888,229
| Recipient | CHRYSALIS BIOTHERAPEUTICS, INC. UEI XW1VFGGRLDW3 |
|---|---|
| Award ID | 75A50119C00016 |
| Award amount | $24,888,229 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Start date | Jul 1, 2019 |
| End date | Feb 15, 2023 |
| Place of performance | GALVESTON, TX |
| Record updated | Sep 14, 2022 |
View the official award record
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids